DBVT FY 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-15.9% YoY

Gross Profit

-$15M-322.9% margin

Operating Income

-$97M-2013.1% margin

Net Income

-$96M-2006.3% margin

EPS (Diluted)

$-6.20

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$56M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$247M

Total Liabilities

$52M

Stockholders' Equity

$194M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$6M	-15.9%
Gross Profit	-$15M	-$4M	-334.8%
Operating Income	-$97M	-$99M	+2.0%
Net Income	-$96M	-$98M	+1.5%